Antibiotic potential for cannabis molecule
Research establishes antibiotic potential for cannabis molecule: Synthetic cannabidiol, better known as CBD, has been shown for the first time…
Global Reach
Sabin Vaccine Institute researchers to investigate COVID-19 misinformation
Sabin Vaccine Institute Funds Researchers to Investigate COVID-19 Misinformation, Design Solutions to Increase Vaccine Acceptance. The Sabin Vaccine Institute (Sabin)…
DigiHEST: How we reached 29 countries in two days
DigiHEST: How we reached 29 countries in two days: The David Nott Foundation recently completed our first digital, live-streamed surgical…
Science scepticism may be reinforced by UK rush to approve vaccines
COVID-19: Science scepticism may be reinforced by UK rush to approve vaccines: Former director of public health Professor John Ashton…
AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK
AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK: The University of Oxford welcomes the news that the UK…
WHO issues validation for a COVID-19 vaccine
WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access: The World…
Things we know at the end of 2020 (part 2)
Things we know at the end of 2020 (part 2): From lockdowns and travels bans to isolation and testing queues,…
Antimicrobial resistant diseases outside of EU
Surveillance of antimicrobial resistant diseases could be more challenging outside of the European Union: In a new report from the…
Things we know at the end of 2020 (part 1)
2020, what a year! Melbourne University researchers, Zena Cumpston, Professor Andrew Dawson, Professor Peter Doherty AC, and Professor Guay Lim…
Epidemic preparedness – a wise investment: the Uganda story
With an Ebola outbreak ongoing in the neighbouring Democratic Republic of the Congo in 2019, authorities in Uganda stepped up…